Abstract
During the oogenesis of Xenopus laevis, oocytes accumulate maternal materials for early embryo development. As the transcription activity of the oocyte is silenced at the fully grown stage and the global genome is reactivated only by the mid-blastula embryo stage, the translation of maternal mRNAs accumulated during oocyte growth should be accurately regulated. Previous evidence has illustrated that the poly(A) tail length and RNA binding elements mediate RNA translation regulation in the oocyte. Recently, RNA methylation has been found to exist in various systems. In this study, we sequenced the N6-methyladenosine (m6A) modified mRNAs in fully grown germinal vesicle-stage and metaphase II-stage oocytes. As a result, we identified 4207 mRNAs with m6A peaks in germinal vesicle-stage or metaphase II-stage oocytes. When we integrated the mRNA methylation data with transcriptome and proteome data, we found that the highly methylated mRNAs showed significantly lower protein levels than those of the hypomethylated mRNAs, although the RNA levels showed no significant difference. We also found that the hypomethylated mRNAs were mainly enriched in the cell cycle and translation pathways, whereas the highly methylated mRNAs were mainly associated with protein phosphorylation. Our results suggest that oocyte mRNA methylation can regulate cellular translation and cell division during oocyte meiotic maturation and early embryo development.
Keywords: embryo, meiosis, oocyte, RNA methylation, translation
Introduction
During oogenesis in animals like Xenopus laevis, mouse, and human, germinal vesicle (GV)-stage3 oocytes gradually achieve maximum size, and genomic transcription activity is silenced (1, 2). After that, the fully grown GV oocytes resume meiosis and develop to metaphase of the second meiosis (MII) stage. Then the oocyte is fertilized by sperm to form a zygote. The zygote starts mitosis, and embryo development is initiated. As embryo genomic transcription is not reactivated until embryo development to the mid-blastula stage for X. laevis (3) or the 2-cell to 16-cell stages for mammals (4–7), oocytes or embryos need the maternal RNAs accumulated during oocyte growth to support new protein synthesis.
As the synthesis of new proteins such as cyclins is of importance for the meiotic and mitotic events, the translation of maternal mRNAs during oocyte meiotic maturation and early embryo development should be precisely controlled. Previous data have shown that there are mainly two methods for cells to control the maternal mRNA translation in oocyte or early embryo protein binding to the cytoplasmic polyadenylation elements (CPEs) in maternal mRNAs and controlling the polyadenylation of the mRNA poly(A) tails (8). In most cases, shortened poly(A) tails of mRNAs repress their translation, whereas elongated poly(A) tails activate translation (9). The poly(A) tail length of oocyte mRNA is mainly associated with cytoplasmic polyadenylation, which is controlled by RNA binding proteins and associated proteins. The maternal mRNAs, whose 3′ UTR contains a cis-element CPE, could be bonded by CPE binding protein (CPEB) (10). When CPEB is phosphorylated under stimulation of progesterone, it recruits and binds to the cleavage and polyadenylation-specific factor. The cleavage and polyadenylation-specific factor then recruits poly(A) polymerase to the mRNA end and mediates poly(A) tail elongation and promotes mRNA translation (11).
In addition to the poly(A) tail and CPE-mediated mRNA translation regulation, recent evidence revealed a correlation between RNA translation and an RNA-specific modification called N6-methyladenosine (m6A) (12, 13). It has been shown that m6A modifications have different effects on mRNA translation when the m6A modifications occur at different regions of the mRNAs (14–16). RNA methylation at the 5′ UTR could promote mRNA translation, whereas RNA methylation at the last exons participated in the 3′ UTR regulation of mRNAs (15, 16). By knocking out the m6Awriter Mettl3, mRNA methylation was also found to play important roles in other cellular events such as cell differentiation and RNA degradation (17).
As transcription is silenced in fully grown oocytes and early embryos, mRNA translation regulation is essential for biological events during this period. To investigate whether m6Amodification takes part in RNA translation regulation in the X. laevis oocyte and its potential roles in oocyte maturation and embryo development, we sequenced m6A-modified mRNAs in fully grown GV-stage and MII-stage X. laevis oocytes and compared the m6A-seq data with the transcriptome and proteome data.
Results
m6A-Seq of GV- and MII-stage Oocytes in X. laevis
m6A-modified mRNAs of GV- and MII-stage oocytes from X. laevis (supplemental Fig. S1) were isolated and analyzed according to the methods described by Dominissini et al. (18). After mapping the methylated RNA fragments to the transcriptome of X. laevis (X. laevis v7.1 from Xenbase) (19), we found that 4207 mRNAs (4128 in GV oocytes and 3820 in MII oocytes) were methylated in GV- or MII-stage oocytes (supplemental Dataset S1).
According to the height of the m6Apeaks, we divided these mRNAs into three classes: m6A high mRNAs, m6A medium mRNAs, and m6A low mRNAs. From these results we found that the m6A modification was maintained in 1674 mRNAs during oocyte maturation from GV to MII stage, but in 2400 mRNAs the m6A levels were decreased, and in 133 mRNAs the m6A levels were increased (Fig. 1A).
FIGURE 1.
Summary of the m6A-modified mRNAs in X. laevis oocytes. A, mRNA methylation changes during oocyte development from GV stage to MII stage. B, conservative m6A motifs in X. laevis GV and MII oocytes. C, distributions of m6A modification sites in the mRNAs. 0 represents the position of the transcription start site in the left panels and the transcription end site in the right panels.
Using the m6A peak-corresponding mRNA sequences, we predicted the conservative m6Amotifs in X. laevis oocytes. As described for human and mouse cells, mRNA methylation in X. laevis oocytes also occurred at the GGACU motifs (Fig. 1B). By analyzing the m6A peak positions along the mRNAs, we found that the m6A peaks were mainly distributed downstream of the coding DNA sequence (CDS) start sites and around the CDS end sites (Fig. 1C).
To analyze the association between m6A peak height and mRNA level in oocytes, we integrated the m6A-seq data with the transcriptome data published by Charlier et al. (20) (supplemental Figs. S1 and S2). From the transcriptome data, we found 1030 genes with detected m6A modifications. The m6A levels of these genes decreased from GV stage to MII stage (p < 0.01, supplemental Fig. S2, A and B). In addition, we also found that there was no obvious relativity between the m6A peak heights and the mRNA levels (supplemental Fig. S2, C and D). Next we compared the ratios of m6A peak height/mRNA level in GV and MII oocytes and found that most ratios of m6A peak height/mRNA level were decreased from GV stage to MII stage (supplemental Fig. S2, E–H).
Gene Set Enrichment Analysis of the Methylated mRNA-associated Pathways in X. laevis Oocytes
To know whether RNA methylation participates in oocyte maturation and embryo development, we analyzed the m6A -modified, mRNA-enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways through the DAVID tools (21). From the results (supplemental Dataset S2), we could see that the highly or moderately methylated mRNAs mainly enriched in pathways like ErbB signaling, progesterone-mediated oocyte maturation, and cell cycle. However, the hypomethylated mRNAs mainly enriched in pathways like RNA degradation, DNA replication, ribosome, spliceosome, pentose phosphate pathway, and glycolysis/gluconeogenesis.
To further assess the biological functions of these m6A-modified mRNAs in Xenopus oocytes, we annotated the Xenopus mRNAs using BLAST on the Biocloud platform. From the gene ontology annotation results, we could find that the oocyte m6A-modified mRNAs were mainly associated with biological processes like transcription, protein phosphorylation, and cell division. Interestingly, in the m6A-modified mRNAs, there were 443 whose proteins had ATP binding functions, and 354 had zinc ion binding functions (supplemental Dataset S3).
The Relationship between mRNA Methylation and mRNA Translation
To investigate whether mRNA methylation is related to mRNA translation, we integrated our mRNA methylation data and the transcriptome and proteome data from Smits et al. (22). In the transcriptome and proteome data, Smits et al. (22) revealed the RNA and protein levels in the egg and embryo (supplemental Fig. S1) of X. laevis. Through BLAST, the information of 723 m6A-modified mRNAs were identified in the RNA/protein profile data. From the profile data, we found that the RNA levels (log10 RNA RPKM values) of high m6A peak mRNAs, detected in GV or MII stage oocytes, were higher than the levels of the total RNAs (in eggs or embryos); however, the protein levels (log10 protein amount/femtomole) were lower than the levels of total proteins (Fig. 2). Compared with the highly methylated mRNAs, the hypomethylated RNAs showed significantly higher protein levels (Fig. 3; p values shown in supplemental Dataset S4). These results suggest that m6A modification may be associated with mRNA translation in oocytes or even in early embryos.
FIGURE 2.
Scatterplot of the m6A-modified mRNAs in the transcriptome/proteome data. The top panels show transcriptome/proteome data in X. laevis eggs, and the bottom panels show data in early embryos. In the scatterplot, we marked the m6A-modified mRNAs of the GV oocytes in the left panels and the data of MII oocyte in the right panels.
FIGURE 3.
Boxplot of the RNA levels and protein levels of m6A-modified mRNAs. A and B, the RNA (A) and protein (B) levels of mRNAs with different m6A modification levels. m6A high, medium, and low represent mRNAs that were methylated with high, medium, or low rates. The p values are listed in supplemental Dataset S4.
To analyze whether the mRNA positions (5′ UTR, CDS, and 3′ UTR) of RNA methylation are associated with translation, we extracted mRNAs whose m6A modification only occurred at the 5′ UTR, 5′-terminal CDS, 3′-terminal CDS, or 3′ UTR from the highly methylated RNAs in GV oocytes (Fig. 4 and supplemental Fig. S3). In Fig. 4 we can see that the mRNAs whose 5′-terminal CDSs or 3′-terminal CDSs were methylated showed lower protein levels compared with the other sets. In addition, mRNAs whose m6A modification occurred at the 3′ UTR, in contrast, showed higher median protein levels (p values are shown in supplemental Dataset S4). These results suggest that CDS region RNA methylation may suppress mRNA translation.
FIGURE 4.
The RNA levels and protein levels of hypermethylated mRNAs in GV oocytes. A, the RNA levels in eggs and embryos of mRNAs that are m6A-modified in GV-stage oocytes. B, the protein levels in eggs and embryos of mRNAs that are m6A-modified in GV-stage oocytes. C and D, scatterplot of the hypermethylated mRNAs in the transcriptome/proteome data of X. laevis eggs and embryos. The p values for A and B are listed in supplemental Dataset S4.
In addition, we also integrated our data with the X. laevis embryo (supplemental Fig. S1) proteome data published by Peshkin et al. (23). As a result, we also found that the hypermethylated RNAs in eggs have a lower protein concentration distribution. As for the hypermethylated RNAs, these RNAs, whose m6A modification mainly occurred in CDS regions, showed a lower protein level distribution (supplemental Fig. S4). From the protein profile data calculated by Peshkin et al. (23), we found that hypermethylated RNAs showed a lower protein synthesis rate (supplemental Fig. S5).
Discussion
When X. laevis oocytes develop to the fully grown GV stage, their transcription activity is silenced. After maturation (about 6 h), MII-stage oocytes are fertilized by spermatozoa, and the oocytes are transformed into fertilized eggs. The fertilized eggs then develop to mid-blastula stage embryos (50–90 min), at which stage the embryonic genome is reactivated, and global transcription is initiated. From the fully grown GV oocytes to the mid-blastula embryos, oocyte maturation and embryo development mainly rely on the maternal factors accumulated in oocytes (24). For oocyte mRNAs, their translation is controlled strictly to satisfy the development requirements. Previous evidence showed that oocyte mRNA translation is controlled by two mechanisms: poly(A) tail length-correlated translation efficiency and 3′ UTR element-mediated mRNA translation activation. Recently, evidence suggested a possible association of translation with RNA methylation (12, 16, 25), indicating that the 5′ UTR m6A modification could initiate the translation of non-capped mRNAs. Through integrating the m6A-seq data and transcriptome/proteome data in X. laevis, we investigated m6A modification and possible roles of oocyte mRNAs. We found that mRNAs in which the CDS region was m6A-modified showed low protein levels, but mRNA with an m6A-modified 3′ UTR showed high protein levels. Our results suggest that RNA methylation is involved in RNA translation regulation in X. laevis oocyte maturation and further embryo development. Thus, we reveal a mechanism regulating maternal mRNA dormancy or translation in early development. Our data also suggest that m6A may play different roles according to their positions. The correlation of CDS region m6A modification and low protein level may suggest that m6A modification represses the translation elongation of mRNAs.
Our results also showed a decrease in RNA methylation during oocyte development from the GV stage to MII stage. As there was no transcription activity in these oocytes, we inferred that there were two events that may induce this RNA methylation decrease: active RNA demethylation and RNA degradation in the MII stage. The RNA methylation pattern changes during oocyte meiosis may also be a mechanism for the oocyte to control mRNA translation. Recent evidence has shown that, in addition to Mettl3, there were other enzymes, like Mettl14 (26), Wilms tumor 1-associated protein (Wtap) (27), and KIAA1429 (28), also involved in the RNA methylation process. On the other hand, two m6A erasers, fat mass and obesity-associated (Fto) (29) and alkB homolog 5 RNA demethylase (Alkbh5) (30), have been found to be involved in m6A modification in mammalian cells (31). These findings suggest that the regulation of RNA methylation in eukaryotic cells is finely regulated through these m6A modification-associated factors. Microarray data about mouse oocyte development (32) have shown that both the m6A writers Mettl3 and Mettl14 and the m6A eraser Alkbh5 were expressed highly in growing oocytes, indicating that mRNA m6A modifications may exist in a dynamic pattern during oocyte growth. In any case, the functions of these m6A-associated enzymes and cofactors should be further analyzed to reveal the regulation of RNA methylation in oocytes and their biological functions.
In our study, we found numerous oocyte meiosis- and early embryo development-associated genes whose mRNAs are methylated. For example, cyclin B2 (ccnb2) is required for X. laevis oocyte bipolar spindle formation, and evidence showed that its protein levels increased in MII-stage oocytes (33). mos is also essential for X. laevis oocyte meiosis resumption (34) and MII stage maintenance (35, 36). Our data showed that the m6A modification in ccnb2 and mos mRNAs decreased in the 3′ terminal of the CDS region but showed no obvious change at the 5′ UTR (supplemental Fig. S6). cdt1, whose m6A modification decreased at the CDS region, has been proven to play roles in DNA replication in embryos (37–39). The m6A modification changes of these key factors indicate that RNA methylation is involved in meiosis regulation and early embryo development.
Experimental Procedures
X. laevis Oocyte Collection
Feeding and handling of X. laevis were conducted in accordance with the Animal Research Committee policies of the Institute of Zoology, Chinese Academy of Sciences. Sexually mature X. laevis females were injected with 50 IU of pregnant mare serum gonadotropin 5 days before collection of GV-stage oocytes. Before the surgery, the X. laevis was buried under ice for about 30 min until it reached complete anesthesia. After making a small incision off the middle line of the belly, a part of the ovary was removed with forceps and scissors and placed in M199-HEPES medium. We then sutured the incision and let the X. laevis recover under a moist tissue until fully awake, and then individuals were submerged in water supplemented with penicillin. The excised ovary was cut into small pieces and transferred to a 50-ml tube containing 40 ml of M199-HEPES with 0.2% collagenase type I 4These oocytes were washed with fresh M199-HEPES and aliquoted in 1.5-ml tubes. After snap-freezing in liquid nitrogen, these oocytes were stored at −80 °C until use. For the ovulation of MII eggs, the X. laevis was injected with 500 IU of human chorionic gonadotropin. After ovulation, we collected the healthy MII oocytes and aliquoted the oocytes in 1.5-ml tubes. After snap-freezing in liquid nitrogen, these oocytes were stored at −80 °C until use.
RNA Preparation
Total RNAs of GV- or MII-stage oocytes were extracted using TRIzol reagent (Life Technologies). To avoid DNA contamination, all samples were treated with Turbo DNase (Life Technologies). RNA samples were chemically fragmented into about 100-nt fragments by incubating in fragmentation buffer (10 mm ZnCl2 and 10 mm Tris-HCl (pH 7)) for 15 min at 94 °C. The fragmentation reaction was stopped by adding 0.05 m EDTA, and the RNAs were collected by standard ethanol precipitation.
m6A-Seq
m6A sequencing was performed as described previously Dominissini et al. (18) with little modification. Briefly, 200 μl of protein A bead slurry (Thermo Fisher Scientific) was blocked by incubating at room temperature for 1 h with 1 ml of immunoprecipitation buffer (150 mm NaCl, 0.1% Igepal CA-630, and 10 mm Tris-HCl (pH 7.4)) supplemented with 50 mg/ml BSA and 200 units of RNasin (Promega). Then the fragmented RNAs (3 mg) were incubated at 4 °C for 1 h with 50 μl of blocked protein A beads to reduce nonspecific binding. After centrifugation at 4 °C, 2500 × g for 3 min, we collected the RNA supernatant and incubated it at 4 °C for 2 h with 12.5 μg of purified rabbit anti-m6A polyclonal antibody (Synaptic Systems). The RNA/antibody mixture was incubated with 50 μl of blocked protein A beads for an additional 2 h at 4 °C. After extensive washing, the bound RNAs were eluted by competition with 0.5 mg/ml N6-methyladenosine (Sigma-Aldrich). The eluted RNAs were precipitated with ethanol and resuspended in nuclease-free water. Finally, the RNA library was generated with an mRNA sequencing kit (Illumina) and sequenced on an Illumina HiSeq2000 platform. The raw data of the sequencing reads were uploaded to the sequence read archive (accession no. SRR3667693).
m6A-Seq Data Analysis
The X. laevis oocyte m6A-seq data were analyzed as described in the protocol by Dominissini et al. (18) with some modifications. Briefly, the RNA-seq reads were mapped to the mRNAs of X. laevis collected by Xenbase (19) using Bowtie software (40). The Bowtie-generated SAM files were treated using MACS software (41) to identify the m6A peak positions in the RNAs. The 100-nt RNA fragments including methylation sites were extracted and analyzed with MEME software (42) to construct the conservative m6A motif in X. laevis. To analyze the m6A sites distribution, we extracted the UTR and CDS information of X. laevis mRNAs from NCBI GenBank. To visualize the m6A peaks in RNAs, we wrote Python scripts and displayed the m6A peaks in SVG format. For the RNAs with m6A peaks, according to the height of the peak, we divided the m6A-modified RNAs into three classes: high (read depth > 60), medium (read depth between 30 and 60) and low (read depth < 30) methylated RNAs. To annotate the X. laevis mRNAs, we blasted the mRNA sequences to the GO dataset using Annofunction software on the Biocloud website.
Integration of m6A-Seq Data with Transcriptome and Proteome Data
The X. laevis oocyte and embryo omic data published by Smits et al. (22) and Peshkin et al. (23) were used for integration analysis of oocyte m6A data. As different reference genome or gene IDs were used in different research groups, we searched the corresponding gene ID using BLAST. All gene expression data we used were calculated by the authors themselves.
Author Contributions
S. T. Q., J. Y. M., and Q. Y. S. designed the experiments. S. T. Q., Z. B. W., L. G., and Y. H. performed the experiments. J. Y. M. analyzed the data, and J. Y. M. and Q. Y. S. wrote the paper.
Supplementary Material
Acknowledgments
We thank Prof. C. M. Zhang at Peking University for providing X. laevis for this study.
This work is supported by Ministry of Science and Technology of China Grant JFYS2016ZY05001886. The authors declare that they have no conflicts of interest with the contents of this article.

This article contains supplemental Figs. S1–S6 and Datasets S1–S4.
The raw data of sequencing reads were uploaded to the SRA under accession number SRR3667693.
- GV
- germinal vesicle
- MII
- metaphase of the second meiosis
- CPE
- cytoplasmic polyadenylation element
- CPEB
- cytoplasmic polyadenylation element binding protein
- CDS
- coding DNA sequence
- m6A
- N6-methyladenosine
- seq
- sequencing.
References
- 1. Bellier S., Dubois M. F., Nishida E., Almouzni G., and Bensaude O. (1997) Phosphorylation of the RNA polymerase II largest subunit during Xenopus laevis oocyte maturation. Mol. Cell. Biol. 17, 1434–1440 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Miyara F., Migne C., Dumont-Hassan M., Le Meur A., Cohen-Bacrie P., Aubriot F. X., Glissant A., Nathan C., Douard S., Stanovici A., and Debey P. (2003) Chromatin configuration and transcriptional control in human and mouse oocytes. Mol. Reprod. Dev. 64, 458–470 [DOI] [PubMed] [Google Scholar]
- 3. Lee M. T., Bonneau A. R., and Giraldez A. J. (2014) Zygotic genome activation during the maternal-to-zygotic transition. Annu. Rev. Cell Dev. Biol. 30, 581–613 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Prather R. S. (2010) Whatever happened to the “cell-block” during mammalian embryogenesis? Mol. Reprod. Dev. 77, NA. [DOI] [PubMed] [Google Scholar]
- 5. Graf A., Krebs S., Heininen-Brown M., Zakhartchenko V., Blum H., and Wolf E. (2014) Genome activation in bovine embryos: review of the literature and new insights from RNA sequencing experiments. Animal Reprod. Sci. 149, 46–58 [DOI] [PubMed] [Google Scholar]
- 6. Yu C., Ji S. Y., Dang Y. J., Sha Q. Q., Yuan Y. F., Zhou J. J., Yan L. Y., Qiao J., Tang F., and Fan H. Y. (2016) Oocyte-expressed yes-associated protein is a key activator of the early zygotic genome in mouse. Cell Res. 26, 275–287 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Yu C., Ji S. Y., Sha Q. Q., Dang Y., Zhou J. J., Zhang Y. L., Liu Y., Wang Z. W., Hu B., Sun Q. Y., Sun S. C., Tang F., and Fan H. Y. (2016) BTG4 is a meiotic cell cycle-coupled maternal-zygotic-transition licensing factor in oocytes. Nat. Struct. Mol. Biol. 23, 387–394 [DOI] [PubMed] [Google Scholar]
- 8. Radford H. E., Meijer H. A., and de Moor C. H. (2008) Translational control by cytoplasmic polyadenylation in Xenopus oocytes. Biochim. Biophys. Acta 1779, 217–229 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Stebbins-Boaz B., Hake L. E., and Richter J. D. (1996) CPEB controls the cytoplasmic polyadenylation of cyclin, Cdk2 and c-mos mRNAs and is necessary for oocyte maturation in Xenopus. EMBO J. 15, 2582–2592 [PMC free article] [PubMed] [Google Scholar]
- 10. Hake L. E., and Richter J. D. (1994) CPEB is a specificity factor that mediates cytoplasmic polyadenylation during Xenopus oocyte maturation. Cell 79, 617–627 [DOI] [PubMed] [Google Scholar]
- 11. Mendez R., Murthy K. G., Ryan K., Manley J. L., and Richter J. D. (2000) Phosphorylation of CPEB by Eg2 mediates the recruitment of CPSF into an active cytoplasmic polyadenylation complex. Mol. Cell 6, 1253–1259 [DOI] [PubMed] [Google Scholar]
- 12. Zhou J., Wan J., Gao X., Zhang X., Jaffrey S. R., and Qian S. B. (2015) Dynamic m6A mRNA methylation directs translational control of heat shock response. Nature 526, 591–594 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Fu Y., Dominissini D., Rechavi G., and He C. (2014) Gene expression regulation mediated through reversible m6A RNA methylation. Nat. Rev. Genet. 15, 293–306 [DOI] [PubMed] [Google Scholar]
- 14. Lee M., Kim B., and Kim V. N. (2014) Emerging roles of RNA modification: m6A and U-tail. Cell 158, 980–987 [DOI] [PubMed] [Google Scholar]
- 15. Ke S., Alemu E. A., Mertens C., Gantman E. C., Fak J. J., Mele A., Haripal B., Zucker-Scharff I., Moore M. J., Park C. Y., Vagbo C. B., Kussnierczyk A., Klungland A., Darnell J. E. Jr., and Darnell R. B. (2015) A majority of m6A residues are in the last exons, allowing the potential for 3′ UTR regulation. Genes Dev. 29, 2037–2053 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Meyer K. D., Patil D. P., Zhou J., Zinoviev A., Skabkin M. A., Elemento O., Pestova T. V., Qian S. B., and Jaffrey S. R. (2015) 5′ UTR m6A promotes cap-independent translation. Cell 163, 999–1010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Geula S., Moshitch-Moshkovitz S., Dominissini D., Mansour A. A., Kol N., Salmon-Divon M., Hershkovitz V., Peer E., Mor N., Manor Y. S., Ben-Haim M. S., Eyal E., Yunger S., Pinto Y., Jaitin D. A., Viukov S., et al. (2015) Stem cells. m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation. Science 347, 1002–1006 [DOI] [PubMed] [Google Scholar]
- 18. Dominissini D., Moshitch-Moshkovitz S., Salmon-Divon M., Amariglio N., and Rechavi G. (2013) Transcriptome-wide mapping of N6-methyladenosine by m6A-seq based on immunocapturing and massively parallel sequencing. Nat. Protoc. 8, 176–189 [DOI] [PubMed] [Google Scholar]
- 19. Karpinka J. B., Fortriede J. D., Burns K. A., James-Zorn C., Ponferrada V. G., Lee J., Karimi K., Zorn A. M., and Vize P. D. (2015) Xenbase, the Xenopus model organism database: new virtualized system, data types and genomes. Nucleic Acids Res. 43, D756–763 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Charlier C., Montfort J., Chabrol O., Brisard D., Nguyen T., Le Cam A., Richard-Parpaillon L., Moreews F., Pontarotti P., Uzbekova S., Chesnel F., and Bobe J. (2012) Oocyte-somatic cells interactions, lessons from evolution. BMC Genomics 13, 560. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Huang da W, Sherman B. T., and Lempicki R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 [DOI] [PubMed] [Google Scholar]
- 22. Smits A. H., Lindeboom R. G., Perino M., van Heeringen S. J., Veenstra G. J., and Vermeulen M. (2014) Global absolute quantification reveals tight regulation of protein expression in single Xenopus eggs. Nucleic Acids Res. 42, 9880–9891 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Peshkin L., Wühr M., Pearl E., Haas W., Freeman R. M. Jr., Gerhart J. C., Klein A. M., Horb M., Gygi S. P., and Kirschner M. W. (2015) On the relationship of protein and mRNA dynamics in vertebrate embryonic development. Dev. Cell 35, 383–394 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Heasman J. (2006) Patterning the early Xenopus embryo. Development 133, 1205–1217 [DOI] [PubMed] [Google Scholar]
- 25. Lin S., Choe J., Du P., Triboulet R., and Gregory R. I. (2016) The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol. Cell 62, 335–345 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Liu J., Yue Y., Han D., Wang X., Fu Y., Zhang L., Jia G., Yu M., Lu Z., Deng X., Dai Q., Chen W., and He C. (2014) A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat. Chem. Biol. 10, 93–95 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Ping X. L., Sun B. F., Wang L., Xiao W., Yang X., Wang W. J., Adhikari S., Shi Y., Lv Y., Chen Y. S., Zhao X., Li A., Yang Y., Dahal U., Lou X. M., et al. (2014) Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 24, 177–189 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Schwartz S., Mumbach M. R., Jovanovic M., Wang T., Maciag K., Bushkin G. G., Mertins P., Ter-Ovanesyan D., Habib N., Cacchiarelli D., Sanjana N. E., Freinkman E., Pacold M. E., Satija R., Mikkelsen T. S., et al. (2014) Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5′ sites. Cell Rep. 8, 284–296 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Jia G., Fu Y., Zhao X., Dai Q., Zheng G., Yang Y., Yi C., Lindahl T., Pan T., Yang Y. G., and He C. (2011) N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat. Chem. Biol. 7, 885–887 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Zheng G., Dahl J. A., Niu Y., Fedorcsak P., Huang C. M., Li C. J., Vågbø C. B., Shi Y., Wang W. L., Song S. H., Lu Z., Bosmans R. P., Dai Q., Hao Y. J., Yang X., et al. (2013) ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol. Cell 49, 18–29 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Cao G., Li H. B., Yin Z., and Flavell R. A. (2016) Recent advances in dynamic m6A RNA modification. Open Biol. 6, 160003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Pan H., O'Brien M. J., Wigglesworth K., Eppig J. J., and Schultz R. M. (2005) Transcript profiling during mouse oocyte development and the effect of gonadotropin priming and development in vitro. Dev. Biol. 286, 493–506 [DOI] [PubMed] [Google Scholar]
- 33. Yoshitome S., Furuno N., Prigent C., and Hashimoto E. (2012) The subcellular localization of cyclin B2 is required for bipolar spindle formation during Xenopus oocyte maturation. Biochem. Biophys. Res. Commun. 422, 770–775 [DOI] [PubMed] [Google Scholar]
- 34. Peter M., Labbé J. C., Doree M., and Mandart E. (2002) A new role for Mos in Xenopus oocyte maturation: targeting Myt1 independently of MAPK. Development 129, 2129–2139 [DOI] [PubMed] [Google Scholar]
- 35. Colledge W. H., Carlton M. B., Udy G. B., and Evans M. J. (1994) Disruption of c-mos causes parthenogenetic development of unfertilized mouse eggs. Nature 370, 65–68 [DOI] [PubMed] [Google Scholar]
- 36. Araki K., Naito K., Haraguchi S., Suzuki R., Yokoyama M., Inoue M., Aizawa S., Toyoda Y., and Sato E. (1996) Meiotic abnormalities of c-mos knockout mouse oocytes: activation after first meiosis or entrance into third meiotic metaphase. Biol. Reprod. 55, 1315–1324 [DOI] [PubMed] [Google Scholar]
- 37. Narasimhachar Y., and Coué M. (2009) Geminin stabilizes Cdt1 during meiosis in Xenopus oocytes. J. Biol. Chem. 284, 27235–27242 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Arentson E., Faloon P., Seo J., Moon E., Studts J. M., Fremont D. H., and Choi K. (2002) Oncogenic potential of the DNA replication licensing protein CDT1. Oncogene 21, 1150–1158 [DOI] [PubMed] [Google Scholar]
- 39. Arias E. E., and Walter J. C. (2005) Replication-dependent destruction of Cdt1 limits DNA replication to a single round per cell cycle in Xenopus egg extracts. Genes Dev. 19, 114–126 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Langmead B., Trapnell C., Pop M., and Salzberg S. L. (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Feng J., Liu T., and Zhang Y. (2011) Using MACS to identify peaks from ChIP-seq data. Curr. Protoc. Bioinformatics Chapter 2, Unit 2 14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Machanick P., and Bailey T. L. (2011) MEME-ChIP: motif analysis of large DNA datasets. Bioinformatics 27, 1696–1697 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.




